138 related articles for article (PubMed ID: 37042161)
1. Prospective surveillance for breast cancer-related lymphedema (PROTECT).
Skjødt Rafn B; Jensen S; Bjerre ED; Wittenkamp MC; Benjaminsen K; Christensen LP; Flyger H; Christiansen P; Johansen C
Acta Oncol; 2023 Jul; 62(7):808-813. PubMed ID: 37042161
[No Abstract] [Full Text] [Related]
2. Breast cancer-related lymphedema (BCRL): Should we be doing more or less for the axilla?
Chuang XE; Chia CLK
Ann Acad Med Singap; 2024 Feb; 53(2):67-68. PubMed ID: 38920230
[No Abstract] [Full Text] [Related]
3. Prospective Surveillance for Breast Cancer-Related Arm Lymphedema: A Systematic Review and Meta-Analysis.
Rafn BS; Christensen J; Larsen A; Bloomquist K
J Clin Oncol; 2022 Mar; 40(9):1009-1026. PubMed ID: 35077194
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration.
Aoishi Y; Oura S; Nishiguchi H; Hirai Y; Miyasaka M; Kawaji M; Shima A; Nishimura Y
Breast Cancer; 2020 Sep; 27(5):929-937. PubMed ID: 32270417
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for the development of severe breast cancer-related lymphedema: a retrospective cohort study.
Liu X; Sun K; Yang H; Xia L; Lu K; Meng X; Li Y
BMC Cancer; 2023 Apr; 23(1):361. PubMed ID: 37081431
[TBL] [Abstract][Full Text] [Related]
6. The effect of combined risk factors on breast cancer-related lymphedema: a study using decision trees.
Jinbo K; Fujita T; Kasahara R; Jinbo R; Kisara S; Onobe J; Kimijima I; Yasuda M; Yamamoto Y
Breast Cancer; 2023 Jul; 30(4):685-688. PubMed ID: 36917351
[TBL] [Abstract][Full Text] [Related]
7. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
[TBL] [Abstract][Full Text] [Related]
8. A Lymphedema Surveillance Program for Breast Cancer Patients Reveals the Promise of Surgical Prevention.
Hahamoff M; Gupta N; Munoz D; Lee BT; Clevenger P; Shaw C; Spiguel L; Singhal D
J Surg Res; 2019 Dec; 244():604-611. PubMed ID: 29397949
[TBL] [Abstract][Full Text] [Related]
9. The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients.
Zheng SY; Chen CY; Qi WX; Cai G; Xu C; Cai R; Qian XF; Shen KW; Cao L; Chen JY
Breast; 2023 Apr; 68():142-148. PubMed ID: 36764019
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and prediction model for persistent breast-cancer-related lymphedema: a 5-year cohort study.
Penn IW; Chang YC; Chuang E; Chen CM; Chung CF; Kuo CY; Chuang TY
Support Care Cancer; 2019 Mar; 27(3):991-1000. PubMed ID: 30105666
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Simplified Lymphatic Microsurgical Preventing Healing Approach (SLYMPHA) for the prevention of breast cancer-related lymphedema after axillary lymph node dissection using bioimpedance spectroscopy.
Ozmen T; Layton C; Friedman-Eldar O; Melnikau S; Kesmodel S; Moller MG; Avisar E
Eur J Surg Oncol; 2022 Aug; 48(8):1713-1717. PubMed ID: 35527056
[TBL] [Abstract][Full Text] [Related]
12. Re: "The Early Detection of Breast Cancer Treatment-Related Lymphedema of the Arm" by Vaughan Keeley.
Aso K; Sakai H
Lymphat Res Biol; 2022 Jun; 20(3):355. PubMed ID: 34714149
[No Abstract] [Full Text] [Related]
13. Discussion: Reverse Lymphatic Mapping and Immediate Microsurgical Lymphatic Reconstruction Reduces Early Risk of Breast Cancer-Related Lymphedema.
Liu DZ
Plast Reconstr Surg; 2022 May; 149(5):1070-1071. PubMed ID: 35255057
[No Abstract] [Full Text] [Related]
14. Discussion: Variable Anatomy of the Lateral Upper Arm Lymphatic Channel: An Anatomical Risk Factor for Breast Cancer-Related Lymphedema.
Wu M; Agarwal S
Plast Reconstr Surg; 2023 Aug; 152(2):430-431. PubMed ID: 37498927
[No Abstract] [Full Text] [Related]
15. Occurrence of breast-cancer-related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two-arm randomized clinical trial.
Gennaro M; Maccauro M; Mariani L; Listorti C; Sigari C; De Vivo A; Chisari M; Maugeri I; Lorenzoni A; Aliberti G; Scaperrotta GP; Caraceni A; Pruneri G; Folli S
Cancer; 2022 Dec; 128(24):4185-4193. PubMed ID: 36259883
[TBL] [Abstract][Full Text] [Related]
16. The important role of nighttime compression in breast cancer-related lymphedema treatment.
Brunelle CL; Ag AG
Cancer; 2022 Feb; 128(3):458-460. PubMed ID: 34614203
[No Abstract] [Full Text] [Related]
17. Use of a prospective surveillance model to prevent breast cancer treatment-related lymphedema: a single-center experience.
Yang EJ; Ahn S; Kim EK; Kang E; Park Y; Lim JY; Kim SW
Breast Cancer Res Treat; 2016 Nov; 160(2):269-276. PubMed ID: 27665585
[TBL] [Abstract][Full Text] [Related]
18. Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.
Shah C; Whitworth P; Valente S; Schwarz GS; Kruse M; Kohli M; Brownson K; Lawson L; Dupree B; Vicini FA
Breast Cancer Res Treat; 2023 Feb; 198(1):1-9. PubMed ID: 36566297
[TBL] [Abstract][Full Text] [Related]
19. Breast lymphedema following breast-conserving treatment for breast cancer: current status and future directions.
Brunelle CL; Boyages J; Jung AW; Suami H; Juhel BC; Heydon-White A; Mackie H; Chou SS; Paramanandam VS; Koelmeyer L; Taghian AG
Breast Cancer Res Treat; 2024 Apr; 204(2):193-222. PubMed ID: 38100015
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the Impact of Immediate Lymphatic Reconstruction for the Surgical Prevention of Lymphedema.
Johnson AR; Fleishman A; Granoff MD; Shillue K; Houlihan MJ; Sharma R; Kansal KJ; Teller P; James TA; Lee BT; Singhal D
Plast Reconstr Surg; 2021 Mar; 147(3):373e-381e. PubMed ID: 33620920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
